Artigo Revisado por pares

Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study

2023; Springer Science+Business Media; Volume: 26; Issue: 3 Linguagem: Inglês

10.1007/s12094-023-03295-2

ISSN

1699-3055

Autores

Jesús García-Donás, Guillermo de Velasco, Rodrigo Madurga, Jesús Chamorro, Diana Isabel Rosero, Olatz Etxániz, Jose Luis Pérez‐Gracia, Álvaro Pinto, Diego Cacho, Maria Luiza Ferreira De Barba, Pablo Borrega, Martín Lázaro, Laura Rodríguez, L. Villalobos, Lourdes García, Andrés Cuellar, María Pilar Solís-Hernández, Amalia Castelli González, Cristina Pernaut, Juan Francisco Rodríguez-Moreno,

Tópico(s)

Healthcare cost, quality, practices

Referência(s)